GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (OTCPK:SOMNF) » Definitions » Days Sales Outstanding

SOMNF (SomnoMed) Days Sales Outstanding : 37.49 (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is SomnoMed Days Sales Outstanding?

SomnoMed's average Accounts Receivable for the six months ended in Jun. 2024 was $6.35 Mil. SomnoMed's Revenue for the six months ended in Jun. 2024 was $30.90 Mil. Hence, SomnoMed's Days Sales Outstanding for the six months ended in Jun. 2024 was 37.49.

The historical rank and industry rank for SomnoMed's Days Sales Outstanding or its related term are showing as below:

SOMNF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 28.09   Med: 46.14   Max: 60.54
Current: 34.98

During the past 13 years, SomnoMed's highest Days Sales Outstanding was 60.54. The lowest was 28.09. And the median was 46.14.

SOMNF's Days Sales Outstanding is ranked better than
88.44% of 813 companies
in the Medical Devices & Instruments industry
Industry Median: 65.03 vs SOMNF: 34.98

SomnoMed's Days Sales Outstanding declined from Jun. 2023 (39.21) to Jun. 2024 (37.49).


SomnoMed Days Sales Outstanding Historical Data

The historical data trend for SomnoMed's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed Days Sales Outstanding Chart

SomnoMed Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.58 33.32 37.81 33.30 28.24

SomnoMed Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.95 43.97 39.21 39.63 37.49

Competitive Comparison of SomnoMed's Days Sales Outstanding

For the Medical Devices subindustry, SomnoMed's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SomnoMed's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SomnoMed's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where SomnoMed's Days Sales Outstanding falls into.



SomnoMed Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

SomnoMed's Days Sales Outstanding for the fiscal year that ended in Jun. 2024 is calculated as

Days Sales Outstanding (A: Jun. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Jun. 2024 )) / count ) / Revenue (A: Jun. 2024 )*Days in Period
=( (4.919 + 4.499) / 2 ) / 60.857*365
=4.709 / 60.857*365
=28.24

SomnoMed's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

Days Sales Outstanding (Q: Jun. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Jun. 2024 )) / count ) / Revenue (A: Jun. 2024 )*Days in Period
=( (8.195 + 4.499) / 2 ) / 30.901*365 / 2
=6.347 / 30.901*365 / 2
=37.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SomnoMed  (OTCPK:SOMNF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


SomnoMed Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of SomnoMed's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


SomnoMed Business Description

Traded in Other Exchanges
Address
20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065
SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SomnoMed Headlines

From GuruFocus

Full Year 2022 Somnomed Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

SomnoMed posts record Q4 and delivers on FY22 revenue guidance

By PRNewswire PRNewswire 07-26-2022

Half Year 2022 Somnomed Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Full Year 2020 Somnomed Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Full Year 2019 Somnomed Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Full Year 2023 Somnomed Ltd Earnings Call Transcript

By GuruFocus Research 02-15-2024

Somnomed Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-15-2024

SomnoMed's North America Q1 revenue growth leads the way

By PRNewswire PRNewswire 10-28-2022

Somnomed Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-15-2024